|
|
BGI Genomics Co., Ltd. is a China-based company principally engaged in the diagnosis and research of genomics. The Company's main products and services include reproductive health basic research and clinical application services, basic science research services (genome sequencing, bioinformatics analysis and other multithreaded solutions), complex disease basic research and clinical application services, as well as drugs basic research and clinical application services. The Company mainly provides services for domestic and overseas academic institutions, research institutes, independent laboratories, pharmaceutical companies, hospitals and medical institutions, among others.
Number of employees : 3 585 people.
|
|
|
| 2019 | | CNY (in Million) | % | | Basic Research and Clinical Application Services for Reproductive Health | 1,176 | 42.2% | | Multi-Group Big Data Service and Synthesis | 681.49 | 24.4% | | Comprehensive Solutions for Precision Medical Testing | 571.26 | 20.5% | | Cancer Prevention and Control and Translational Medicine Services | 283.28 | 10.1% | | Basic Research and Clinical Application Services for Infection Prevention and Control | 81.24 | 2.9% | | Other Operating Income | 6.68 | 0.2% |
|
|
|
| 2018 | 2019 | Delta | | CNY (in Million) | % | CNY (in Million) | % | | China | 2,051 | 81.1% | 2,336 | 83.7% | +13.9% | | Europe and Africa | 191.26 | 7.6% | 192.90 | 6.9% | +0.85% | | Asia (including Hong Kong, Macau and Taiwan) | 156.20 | 6.2% | 144.17 | 5.2% | -7.7% | | Americas | 137.58 | 5.4% | 126.87 | 4.5% | -7.79% |
|
|
|
| Vote  | Quantity | Free-Float | Company-owned shares | Total Float |
| Stock A |
1 |
400,100,042 |
400,100,000 |
100.0% |
42 |
0.0% |
100.0% |
|
|
|
| Name | Equities | % | | Jun Wang | 39,422,400 |
15.8% | | Shenzhen Heyu Gaolin Equity Investment LP | 30,867,588 |
12.4% | | Wanjia Asset Management Co., Ltd. | 8,873,347 |
3.56% | | Bosera Asset Management Co., Ltd. | 5,426,435 |
2.18% | | Bgi Genomics Co. Ltd. Esop Ph1 | 4,000,000 |
1.60% | | Jian Hua Wang | 3,935,824 |
1.58% | | China Merchants Fund Management Co., Ltd. | 3,193,979 |
1.28% | | Fullgoal Fund Management Co., Ltd. | 2,423,893 |
0.97% | | E Fund Management Co., Ltd. | 1,986,222 |
0.80% | | Shanghai Gaolin Tongchuang Equity Investment Partnership LP | 1,911,912 |
0.77% |
|
| Company contact information |
|
BGI Genomics Co., Ltd. Block 11, Beishan Industrial Zone Yantian District Shenzhen, Guangdong 518083 Phone : +86.755.36307888 Fax : +86.755.25273620 Web : http://www.genomics.cn |
|
|
|
Chinese listed companies ramp up virus efforts after president's call |
Sector Bio Diagnostics & Testing
Connections : BGI Genomics Co., Ltd. |
Canada
Deutschland
France
Schweiz (DE)
United Kingdom
Report
